Search results

On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program

Griffith University researchers are conducting an experiment at ANSTO that will test a revolutionary physics theory that time reversal symmetry-breaking by neutrinos might cause a time dilation at the quantum scale.

Read about an ANSTO scientist and their work to prepare for a school project or interview.

Consultant appointed to consider a variety of financial, manufacture and import options.

ANSTO is coordinating and facilitating a new cycle of Australian project proposals for the Regional Cooperative Agreement (RCA).

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

Health researchers have developed a new method for producing PET radiotracers.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.